TY - JOUR
T1 - How to monitor pregnancies complicated by fetal growth restriction and delivery before 32 weeks
T2 - post-hoc analysis of TRUFFLE study
AU - Ganzevoort, W.
AU - Mensing van Charante, N.
AU - Thilaganathan, B.
AU - Prefumo, Federico
AU - Arabin, B.
AU - Bilardo, Caterina M.
AU - Brezinka, C.
AU - Derks, J. B.
AU - Diemert, A.
AU - Duvekot, Johannes J.
AU - Ferrazzi, E.
AU - Frusca, T.
AU - Hecher, K.
AU - Marlow, N.
AU - Martinelli, P.
AU - Ostermayer, E.
AU - Papageorghiou, Aris T.
AU - Schlembach, D.
AU - Schneider, K. T M
AU - Todros, T.
AU - Valcamonico, A.
AU - Visser, G. H.A.
AU - van Wassenaer-Leemhuis, A.
AU - Lees, Christoph C.
AU - Wolf, H.
AU - Aktas, Ayse
AU - Borgione, Silvia
AU - Chaoui, Rabih
AU - Cornette, Jerome M J
AU - Diehl, Thilo
AU - van Eyck, J.
AU - Fratelli, Nicola
AU - van Haastert, I. C.
AU - Lobmaier, Silvia
AU - Lopriore, E.
AU - Missfelder-Lobos, Hannah
AU - Mansi, Giuseppina
AU - Martelli, Paola
AU - Maso, Gianpaolo
AU - Maurer-Fellbaum, Ute
AU - Mulder-De Tollenaer, Susanne
AU - Napolitano, Raffaele
AU - Oberto, Manuela
AU - Oepkes, D.
AU - Ogge, Giovanna
AU - van der Post, Joris A. M.
AU - Preston, Lucy
AU - Raimondi, Francesco
AU - Rattue, H.
AU - Reiss, Irwin K M
N1 - Funding Information:
C.C.L. is supported by the National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare National Health Service Trust and Imperial College London, UK. The Trial of Randomized Umbilical and Fetal Flow in Europe study was supported by ZonMw, 2509 AE Den Haag, The Netherlands (grant 94506556), in The Netherlands. In other countries, the study was not funded. A contribution was made to study funding from the Dr Hans Ludwig Geisenhofer Foundation, Munich, Germany.
Publisher Copyright:
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
PY - 2017/6/1
Y1 - 2017/6/1
N2 - Objectives: In the recent TRUFFLE study, it appeared that, in pregnancies complicated by fetal growth restriction (FGR) between 26 and 32 weeks' gestation, monitoring of the fetal ductus venosus (DV) waveform combined with computed cardiotocography (CTG) to determine timing of delivery increased the chance of infant survival without neurological impairment. However, concerns with the interpretation were raised, as DV monitoring appeared to be associated with a non-significant increase in fetal death, and some infants were delivered after 32 weeks, at which time the study protocol no longer applied. This secondary sensitivity analysis of the TRUFFLE study focuses on women who delivered before 32 completed weeks' gestation and analyzes in detail the cases of fetal death. Methods: Monitoring data of 317 pregnancies with FGR that delivered before 32 weeks were analyzed, excluding those with absent outcome data or inevitable perinatal death. Women were allocated randomly to one of three groups of indication for delivery according to the following monitoring strategies: (1) reduced fetal heart rate short-term variation (STV) on CTG; (2) early changes in fetal DV waveform; and (3) late changes in fetal DV waveform. Primary outcome was 2-year survival without neurological impairment. The association of the last monitoring data before delivery and infant outcome was assessed by multivariable analysis. Results: Two-year survival without neurological impairment occurred more often in the two DV groups (both 83%) than in the CTG-STV group (77%), however, the difference was not statistically significant (P = 0.21). Among the surviving infants in the DV groups, 93% were free of neurological impairment vs 85% of surviving infants in the CTG-STV group (P = 0.049). All fetal deaths (n = 7) occurred in the groups with DV monitoring. Of the monitoring parameters obtained shortly before fetal death in these seven cases, an abnormal CTG was observed in only one case. Multivariable regression analysis of factors at study entry demonstrated that a later gestational age, higher estimated fetal weight-to-50th percentile ratio and lower umbilical artery pulsatility index (PI)/fetal middle cerebral artery-PI ratio were significantly associated with normal outcome. Allocation to DV monitoring had a smaller effect on outcome, but remained in the model (P < 0.1). Abnormal fetal arterial Doppler before delivery was significantly associated with adverse outcome in the CTG-STV group. In contrast, abnormal DV flow was the only monitoring parameter associated with adverse outcome in the DV groups, while fetal arterial Doppler, STV below the cut-off used in the CTG-STV group and recurrent decelerations in fetal heart rate were not. Conclusions: In accordance with the findings of the TRUFFLE study on monitoring and intervention management of very preterm FGR, we found that the proportion of infants surviving without neuroimpairment was not significantly different when the decision for delivery was based on changes in DV waveform vs reduced STV on CTG. The uneven distribution of fetal deaths towards the DV groups was probably a chance effect, and neurological outcome was better among surviving children in these groups. Before 32 weeks, delaying delivery until abnormalities in DV-PI or STV and/or recurrent decelerations in fetal heat rate occur, as defined by the study protocol, is likely to be safe and possibly benefits long-term outcome.
AB - Objectives: In the recent TRUFFLE study, it appeared that, in pregnancies complicated by fetal growth restriction (FGR) between 26 and 32 weeks' gestation, monitoring of the fetal ductus venosus (DV) waveform combined with computed cardiotocography (CTG) to determine timing of delivery increased the chance of infant survival without neurological impairment. However, concerns with the interpretation were raised, as DV monitoring appeared to be associated with a non-significant increase in fetal death, and some infants were delivered after 32 weeks, at which time the study protocol no longer applied. This secondary sensitivity analysis of the TRUFFLE study focuses on women who delivered before 32 completed weeks' gestation and analyzes in detail the cases of fetal death. Methods: Monitoring data of 317 pregnancies with FGR that delivered before 32 weeks were analyzed, excluding those with absent outcome data or inevitable perinatal death. Women were allocated randomly to one of three groups of indication for delivery according to the following monitoring strategies: (1) reduced fetal heart rate short-term variation (STV) on CTG; (2) early changes in fetal DV waveform; and (3) late changes in fetal DV waveform. Primary outcome was 2-year survival without neurological impairment. The association of the last monitoring data before delivery and infant outcome was assessed by multivariable analysis. Results: Two-year survival without neurological impairment occurred more often in the two DV groups (both 83%) than in the CTG-STV group (77%), however, the difference was not statistically significant (P = 0.21). Among the surviving infants in the DV groups, 93% were free of neurological impairment vs 85% of surviving infants in the CTG-STV group (P = 0.049). All fetal deaths (n = 7) occurred in the groups with DV monitoring. Of the monitoring parameters obtained shortly before fetal death in these seven cases, an abnormal CTG was observed in only one case. Multivariable regression analysis of factors at study entry demonstrated that a later gestational age, higher estimated fetal weight-to-50th percentile ratio and lower umbilical artery pulsatility index (PI)/fetal middle cerebral artery-PI ratio were significantly associated with normal outcome. Allocation to DV monitoring had a smaller effect on outcome, but remained in the model (P < 0.1). Abnormal fetal arterial Doppler before delivery was significantly associated with adverse outcome in the CTG-STV group. In contrast, abnormal DV flow was the only monitoring parameter associated with adverse outcome in the DV groups, while fetal arterial Doppler, STV below the cut-off used in the CTG-STV group and recurrent decelerations in fetal heart rate were not. Conclusions: In accordance with the findings of the TRUFFLE study on monitoring and intervention management of very preterm FGR, we found that the proportion of infants surviving without neuroimpairment was not significantly different when the decision for delivery was based on changes in DV waveform vs reduced STV on CTG. The uneven distribution of fetal deaths towards the DV groups was probably a chance effect, and neurological outcome was better among surviving children in these groups. Before 32 weeks, delaying delivery until abnormalities in DV-PI or STV and/or recurrent decelerations in fetal heat rate occur, as defined by the study protocol, is likely to be safe and possibly benefits long-term outcome.
KW - cardiotocography
KW - ductus venosus
KW - fetal growth restriction
KW - intrauterine growth restriction
UR - http://www.scopus.com/inward/record.url?scp=85020078461&partnerID=8YFLogxK
U2 - 10.1002/uog.17433
DO - 10.1002/uog.17433
M3 - Article
C2 - 28182335
AN - SCOPUS:85020078461
SN - 0960-7692
VL - 49
SP - 769
EP - 777
JO - Ultrasound in Obstetrics and Gynecology
JF - Ultrasound in Obstetrics and Gynecology
IS - 6
ER -